Chicago Atlantic BDC Earnings Call Transcripts
Fiscal Year 2026
-
Record net investment income and portfolio growth in Q1 2026, driven by strong origination and a focus on senior secured lending in cannabis and non-cannabis markets. Regulatory changes and a robust pipeline support a positive outlook, with ample liquidity and low leverage maintained.
-
The discussion highlighted the unique risk-reward profile and downside protection in cannabis lending, the impact of regulatory changes, and the importance of strong origination and underwriting platforms. Despite capital constraints and sector headwinds, established lenders are positioned to benefit from future market openness.
Fiscal Year 2025
-
Q4 2025 saw strong net investment income and portfolio growth, with a 15.8% yield and no non-accruals. The investment pipeline expanded to $732 million, driven by M&A and positive cannabis policy momentum, while maintaining low leverage and high senior secured exposure.
-
Record new originations and strong net investment income drove portfolio growth and a well-covered dividend. The portfolio remains highly senior secured, under-levered, and differentiated, with robust liquidity and a disciplined approach to risk and underwriting.
-
Q2 saw $39.1M in new investments, a 16.1% yield, and no non-accruals, with net investment income steady at $7.7M. Liquidity remains strong at $125.4M, and a robust $780M pipeline supports continued portfolio growth.
-
Q1 2025 saw strong senior secured lending, a 16.6% yield, and no non-accruals, with $11.9M gross investment income and a $0.34 dividend. A new $100M credit facility supports a $590M pipeline, and leverage remains well below industry averages.
Fiscal Year 2024
-
First full quarter as a BDC saw strong portfolio growth, a 36% dividend increase, and a $100M credit facility. Net investment income rose sharply year-over-year, with a robust pipeline and a focus on disciplined underwriting in cannabis and other underserved markets.
-
Gross investment income rose to $3.2M year-over-year, with a significantly expanded and diversified portfolio post-acquisition. The company maintains a strong cash position, no debt, and expects higher dividends, while focusing on both cannabis and non-cannabis lending amid robust demand for capital.
-
Q2 2024 saw higher investment income and a robust 18% portfolio yield, with net assets impacted by dividends and transaction costs. The investment strategy expanded beyond cannabis, and a major loan portfolio acquisition is set to close in early Q4 2024.